A retrospective analysis of 578 pancreatoduodenectomy patients revealed that 42.91% achieved an ‘ideal outcome’ (io). Key factors enhancing io likelihood included neoadjuvant chemotherapy and neuroendocrine tumors. In contrast, older age and percutaneous transhepatic biliary drainage reduced the odds of achieving io. Notably, patients with io demonstrated significantly improved survival rates, underscoring the potential for refined […]

A study examining minimally invasive surgery (MIS) for hepatic and pancreatic procedures found significant benefits compared to open surgery. Among 8,705 patients, MIS was associated with a mean decrease in 1-year post-discharge healthcare costs of $9,739 and fewer missed workdays. After adjusting for factors such as demographics and comorbidities, the results highlighted that MIS not […]

A study evaluating the Enhanced Recovery After Surgery (ERAS) protocol for laparoscopic common bile duct exploration (LCBDE) found marked improvements in patient outcomes. The ERAS group experienced significantly lower anxiety levels and complication rates (p < 0.05). Additionally, they reported reduced postoperative pain scores, achieving a satisfaction rating of 90% and a recovery time of […]

A systematic review evaluated 1,417 patients undergoing liver resections with either ultrasonic devices or clamp-crushing techniques. While the clamp-crush method yielded shorter operation times, the ultrasonic group demonstrated significantly less blood loss and lower transfusion rates. Both groups had comparable mortality and postoperative bleeding rates; however, the ultrasonic devices were linked to a notably lower […]

A complex parenchyma-sparing hepatectomy was successfully performed on a 61-year-old woman with multiple bilobar colorectal liver metastases after she showed a partial response to second-line chemotherapy. Utilizing advanced three-dimensional reconstruction and intraoperative ultrasound for guidance, clinicians executed a unique transection of several liver segments, significantly preserving healthy tissue while addressing extensive disease. This innovative approach […]

An expert panel from the Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery has established clear criteria for assessing the oncological resectability of hepatocellular carcinoma (HCC). Three classifications were introduced—resectable, borderline resectable 1, and borderline resectable 2—distinguishing treatment strategies and anticipated survival outcomes. This consensus aims to facilitate discussions on “conversion therapy” and […]

In a study involving 1,558 pancreatic cancer patients, 13.9% exhibited normal carbohydrate antigen 19-9 (ca19-9) levels, linked to significantly longer median survival rates (18.1 vs. 9.7 months). Those with stage IV ca19-9-normal cancer had a 5-year survival chance of 22.4%, compared to 6.8% in the ca19-9-high group. Findings suggest that glucose control, influenced by insulin […]